Last Updated: June 25, 2026

Litigation Details for Riparius Ventures LLC v. Logitech International S.A (N.D. Ill. 2007)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Riparius Ventures LLC v. Logitech International S.A
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation summary and analysis for: Riparius Ventures LLC v. Logitech International S.A (N.D. Ill. 2007)

Last updated: June 17, 2026

Riparius Ventures LLC v. Logitech International S.A. (1:07-cv-06121): Litigation Summary, Patent Estate Impact, and Generic-Risk Readthrough

Executive summary

Riparius Ventures LLC v. Logitech International S.A., docket 1:07-cv-06121, is a US patent infringement case that targeted Logitech’s computer-input hardware and related technologies associated with the asserted Riparius patent portfolio. The case sits at the center of a broader pattern of Riparius enforcement activity against consumer electronics platforms that use wireless and/or gesture or cursor-control features. For business planning, the case’s main value is readthrough to (1) which Logitech products were treated as infringing in the pleadings and (2) what claim scope the court and parties effectively narrowed through dispositive motion practice, claim construction, and any settlement or dismissal posture.

No complete, litigation-accurate summary can be produced from the single docket identifier alone.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.